Immunic, Inc. Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Go back to Immunic, Inc. Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Immunic Inc. (IMUX) Tops Q2 EPS by 1c

August 4, 2022 6:39 AM EDT

Immunic Inc. (NASDAQ: IMUX) reported Q2 EPS of ($0.72), $0.01 better than the analyst estimate of ($0.73).

For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.

... More